Factors affecting long‑term survival in elderly patients undergoing radiotherapy for esophageal carcinoma

Lu,Xiaoxu; Wu,Hui; Wang,Jianhua; Chen,Yongshun; Xu,Jing

doi:10.3892/mco.2014.285

July-August 2014 Volume 2 Issue 4

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

July-August 2014 Volume 2 Issue 4

Full Size Image

Article

Factors affecting long‑term survival in elderly patients undergoing radiotherapy for esophageal carcinoma

Authors:
- Xiaoxu Lu
- Hui Wu
- Jianhua Wang
- Yongshun Chen
- Jing Xu
View Affiliations / Copyright

Affiliations: Department of Radiotherapy, The Affiliated Tumor Hospital of Zhengzhou University, Zhengzhou, Henan 450008, P.R. China
Pages: 571-574
|
Published online on: April 30, 2014

https://doi.org/10.3892/mco.2014.285
Expand metrics +

Abstract

This study was conducted with the aim to analyze the factors affecting the 1‑, 3‑ and 5‑year survival rate of elderly patients with esophageal carcinoma. Between 2004 and 2008, a total of 371 patients aged ≥70 years treated with radiotherapy alone were enrolled in this study. The clinical characteristics and radiotherapy dose were evaluated by survival rate and the 1‑, 3‑ and 5‑year overall survival (OS) rates were found to be 42, 13.2 and 9.16%, respectively. The univariate analysis revealed significant differences in T, N, M and clinical stage and radiotherapy dose (all P‑values <0.05) and no significant differences in gender (all P‑values >0.05). There was a difference in tumor location when only comparing the 3‑ and 5‑year OS rates (P=0.031 and P=0.025, respectively). The multivariate analysis identified clinical stage as an independent factor for the 1‑year OS rate (P=0.003), whereas radiotherapy dose and clinical stage were found to be independent factors for the 3‑ and 5‑year OS rates (all P‑values 0.05). In the analysis of radiotherapy dose, we observed no significant difference in the 1‑year OS rate between the radiation dose (DT) >60 Gy and the 50 Gy≤DT<60 Gy groups (P=0.363); however, there were statistically significant differences in the 3‑year OS rate between the 50 Gy≤DT<60 Gy and the other groups (P=0.039 and P=0.032); there were no significant differences in the 5‑year OS rate among the dose groups (all P‑values >0.05). In conclusion, according to the findings of this retrospective study, radiotherapy alone for elderly patients with esophageal cancer does not appear to be acceptable and there is a need for a more effective treatment. T, N, M and clinical stage and radiotherapy dose were identified as factors significantly affecting the 1‑, 3‑ and 5‑year OS in elderly patients with esophageal carcinoma, although a higher radiotherapy dose with normal fractionation did not appear to improve the OS rate.

View Figures

View References

1	Kosugi S, Sasamoto R, Kanda T, et al: Retrospective review of surgery and definitive chemoradiotherapy in patients with squamous cell carcinoma of the thoracic esophagus aged 75 years or older. Jpn J Clin Oncol. 39:360–366. 2009.PubMed/NCBI
2	Agranovich A, McGahan CE and Gurjal A: Long-term survivorship of esophageal cancer patients treated with radical intent. Can J Gastroenterol. 22:393–398. 2008.PubMed/NCBI
3	Kong J, Li XN, Han C, et al: Treatment outcomes of 792 cases of esophageal carcinoma patients treated with three-dimensional radiotherapy. Chin J Radiat Oncol. 21:421–424. 2012.
4	Liu JF, Wang QZ and Hou J: Surgical treatment for cancer of the oesophagus and gastric cardia in Heibei, China. Br J Surg. 91:90–98. 2004. View Article : Google Scholar
5	Huang SH, O’Sullivan B, Waldron J, et al: Patterns of care in elderly head-and-neck cancer radiation oncology patients: a single-center cohort study. Int J Radiat Oncol Biol Phys. 79:46–51. 2011. View Article : Google Scholar : PubMed/NCBI
6	Huang W, Ren H, Ben Q, et al: Risk of esophageal cancer in diabetes mellitus: a meta-analysis of observational studies. Cancer Causes Control. 23:263–272. 2012. View Article : Google Scholar : PubMed/NCBI
7	Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA Jr, Al-Sarraf M, et al: Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. Jama. 281:1623–1627. 1999. View Article : Google Scholar : PubMed/NCBI
8	Bergquist H, Johnsson A, Hammerlid E, et al: Factors predicting survival in patients with advanced oesophageal cancer: a prospective multicentre evaluation. Aliment Pharmacol Ther. 27:385–395. 2008. View Article : Google Scholar : PubMed/NCBI
9	Tougeron D, Hamidou J, Scotte M, et al: Esophageal cancer in the elderly: an analysis of the factors associated with treatment decisions and outcomes. BMC Cancer. 10:5102010. View Article : Google Scholar : PubMed/NCBI
10	Minsky BD, Pajak TF, Ginsberg RJ, et al: INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 20:1167–1174. 2002. View Article : Google Scholar : PubMed/NCBI
11	Li G and Guo Y: Radiotherapy with esophageal carcinoma aged 80 years or older. Chin J Geriatr. 26:202–203. 2007.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Factors affecting long‑term survival in elderly patients undergoing radiotherapy for esophageal carcinoma

This article is mentioned in:

Abstract

Related Articles